R&D | January 14, 2026
Codexis teams up with Axolabs to advance enzymatic RNA manufacturing
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The demand in Africa for COVID-19 vaccines has declined
The collaboration will support Canada with direct access to rapid pandemic response capabilities
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
Subscribe To Our Newsletter & Stay Updated
